Journal of Analytical Toxicology 2013-09-01

Stability of 3,4-methylenedioxymethampetamine (MDMA), 4-methylmethcathinone (mephedrone) and 3-trifluromethylphenylpiperazine (3-TFMPP) in formalin solution.

Peter D Maskell, L Nitin Seetohul, Alison C Livingstone, Alexandra K Cockburn, Jamie Preece, Derrick J Pounder

Index: J. Anal. Toxicol. 37(7) , 440-6, (2013)

Full Text: HTML

Abstract

Occasionally, the only postmortem samples available for analysis are contaminated with formaldehyde, either due to embalming prior to sampling or because analysis is carried out only when formalin-fixed tissues retained for histological study are available. Formaldehyde reacts with several drugs of forensic interest that contain either a primary or a secondary amine group to form their N-methyl derivatives. We investigated the stability of 3,4-methylenedioxymethampetamine (MDMA), 4-methylmethcathinone (mephedrone) and 3-trifluromethylphenylpiperazine (3-TFMPP) in formalin solutions using three different formaldehyde concentrations (5, 10 and 20%) and three different pHs (3.0, 7.0 and 9.5). Analysis was performed using high-performance liquid chromatography with diode array detection to determine the percentage degradation of each drug over time, up to 60 days. MDMA, mephedrone and 3-TFMPP are unstable in formalin solutions, with the degradation rate increasing with increasing pH. After 28 days in 20% formalin, pH 9.5, there remained 57% of the initial 3-TFMPP concentration, 11% of the initial MDMA concentration and 4% of the initial mephedrone concentration. Forensic toxicologists should be aware that, when analyzing for these drugs in an embalmed body or in tissues stored in formalin solutions, the methylated form of the secondary amine-containing drug could be a more useful analyte than the parent drug.


Related Compounds

Related Articles:

Measuring effects of MDMA (ecstasy) abuse on the rate of cerebral serotonin synthesis.

2014-12-01

[J. Neurochem. 131(5) , 541-5, (2014)]

Brain serotonin synthesis in MDMA (ecstasy) polydrug users: an alpha-[(11) C]methyl-l-tryptophan study.

2014-12-01

[J. Neurochem. 131(5) , 634-44, (2014)]

3,4-Methylenedioxy-methamphetamine induces in vivo regional up-regulation of central nicotinic receptors in rats and potentiates the regulatory effects of nicotine on these receptors.

2013-03-01

[Neurotoxicology 35 , 41-9, (2013)]

Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.

2012-01-01

[J. Psychoactive Drugs 44(5) , 410-7, (2012)]

A case of drug-facilitated sexual assault involving 3,4-methylenedioxy-methylamphetamine.

2013-01-01

[J. Psychoactive Drugs 45(1) , 94-7, (2013)]

More Articles...